Serum levels of high-sensitivity C-reactive protein in acute ischemic stroke and its subtypes: a prospective case-control study
Asia Pacific Journal of Clinical Trials: Nervous System Diseases · 2018 · 3 (4) · 128
DOI: 10.4103/2542-3932.245216 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift Asia Pacific Journal of Clinical Trials: Nervous System Diseases, 2018. Verfasst von DavinderSingh Rana und 4 weiteren Autor:innen. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Themen: Schlaganfall
Abstract (Originalsprache)
Background and objectives: Studies in different populations have shown that ischemic stroke can trigger an acute phase response resulting in a rise of plasma concentration of C-reactive protein (CRP) and high level of high-sensitivity CRP (hsCRP) is a risk factor for ischemic stroke. The objective of this study was to investigate the association of high hsCRP levels (≥ 1 mg/L) with ischemic stroke and its subtypes in Indian patients.
Methods
This prospective observational case-control study included 150 patients (96 males, 54 females; aged 24–81 years) with first acute ischemic stroke who were admitted within 72 hours after onset, and 150 age- and sex-matched healthy controls. The study was conducted from July 2016 to July 2017. The patients were classified according to Trial of ORG 10172 in Acute Stroke Treatment classification. hsCRP levels were assessed in all included stroke patients.
Results
The mean serum level of hsCRP was significantly higher in patients with first acute ischemic stroke than in healthy controls (P Conclusion: High hsCRP level is strongly associated with acute ischemic stroke and its subtypes, and it is an independent predictor of acute ischemic stroke. Ethics: The study was approved by the Sir Ganga Ram Hospital Ethics Committee (EC/07/14/701) on July 5, 2014.
Zitieren
APA
Rana, D., Anand, I., Batra, A., Sethi, P., & Bhargava, S. (2018). Serum levels of high-sensitivity C-reactive protein in acute ischemic stroke and its subtypes: a prospective case-control study. Asia Pacific Journal of Clinical Trials: Nervous System Diseases, 3(4), 128. https://doi.org/10.4103/2542-3932.245216
Vancouver
Rana D, Anand I, Batra A, Sethi P, Bhargava S. Serum levels of high-sensitivity C-reactive protein in acute ischemic stroke and its subtypes: a prospective case-control study. Asia Pacific Journal of Clinical Trials: Nervous System Diseases. 2018;3(4):128. doi:10.4103/2542-3932.245216
BibTeX
@article{Rana2018,
author = {Rana, DavinderSingh and Anand, Ish and Batra, Anuradha and Sethi, PrahladKumar and Bhargava, Seema},
title = {Serum levels of high-sensitivity C-reactive protein in acute ischemic stroke and its subtypes: a prospective case-control study},
journal = {Asia Pacific Journal of Clinical Trials: Nervous System Diseases},
year = {2018},
volume = {3},
number = {4},
pages = {128},
doi = {10.4103/2542-3932.245216}
}
EUVIMED